
Fulgent Genetics, Inc.
Fulgent Genetics, Inc. (FLGT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · FLGT · as of Jun 8, 2026
Key Statistics
Explore Fulgent Genetics, Inc. Data
flgt stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 66.7%
The FLGT analyst consensus is Buy, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $15.00, representing -19.76% downside from the current price of $18.69.
Competitors & Peers
flgt competitorsStock Performance
Full HistoryAbout Fulgent Genetics, Inc.
Fulgent Genetics, Inc. together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The c…
what is fulgent genetics, inc. · flgt stock overview · fulgent genetics, inc. company profile · who is fulgent genetics, inc. ceo · flgt NASDAQ · fulgent genetics, inc. headquarters · fulgent genetics, inc. business segments
About Stock Overview & Key Data
Fulgent Genetics, Inc. (FLGT) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Sep 29, 2016. As of the latest trading session, FLGT stock price is $18.69, with a market capitalization of $530.9M. The stock has returned -14.31% over the past 12 months and -28.85% year-to-date.
According to 9 Wall Street analysts, the consensus rating for Fulgent Genetics, Inc. stock is Buy, with an average 12-month price target of $15.00. In fiscal year 2025, Fulgent Genetics, Inc. reported revenue of $322.7M and net income of -$60.5M. For detailed data — including Fulgent Genetics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Fulgent Genetics, Inc. (FLGT) stock price is $18.69. The stock is traded on NASDAQ under the ticker symbol FLGT. The 52-week range is $13.46 – $31.04.